NCT01520350View on ClinicalTrials.gov

Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study

PHASE3TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Bipolar DisorderDepressive Episode

Interventions

DRUG

Low dose Adjunctive Aripiprazole

low-dose 2-5mg/d for 8 weeks

DRUG

placebo

Placebo

Trial Locations (1)

H4H 1R3

Douglas Mental Health University Institute, Montreal

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Serge Beaulieu

OTHER